Metzker ML . Sequencing technologies - the next generation. Nat Rev Genet 2010; 11: 31–46. CASPubMed Google Scholar
Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR _et al_International Cancer Genome C. International network of cancer genome projects. Nature 2010; 464: 993–998. CASPubMed Google Scholar
Cancer Genome Atlas Research N. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012; 489: 519–525. Google Scholar
Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C et al. Mutational landscape and significance across 12 major cancer types. Nature 2013; 502: 333–339. CASPubMedPubMed Central Google Scholar
Kreso A, O'Brien CA, van Galen P, Gan OI, Notta F, Brown AM et al. Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science 2013; 339: 543–548. CASPubMed Google Scholar
Speicher MR, Pantel K . Tumor signatures in the blood. Nat Biotechnol 2014; 32: 441–443. CASPubMed Google Scholar
Alix-Panabieres C, Pantel K . Circulating tumor cells: liquid biopsy of cancer. Clin Chem 2013; 59: 110–118. CASPubMed Google Scholar
Alix-Panabieres C, Pantel K . Challenges in circulating tumour cell research. Nat Rev Cancer 2014; 14: 623–631. CASPubMed Google Scholar
Haber DA, Velculescu VE . Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. Cancer Discov 2014; 4: 650–661. CASPubMedPubMed Central Google Scholar
Heitzer E, Auer M, Ulz P, Geigl JB, Speicher MR . Circulating tumor cells and DNA as liquid biopsies. Genome Med 2013; 5: 73. PubMedPubMed Central Google Scholar
Krebs MG, Metcalf RL, Carter L, Brady G, Blackhall FH, Dive C . Molecular analysis of circulating tumour cells-biology and biomarkers. Nat Rev Clin Oncol 2014; 11: 129–144. CASPubMed Google Scholar
Yu M, Stott S, Toner M, Maheswaran S, Haber DA . Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 2011; 192: 373–382. CASPubMedPubMed Central Google Scholar
Pantel K, Brakenhoff RH . Dissecting the metastatic cascade. Nat Rev Cancer 2004; 4: 448–456. CASPubMed Google Scholar
Bednarz-Knoll N, Alix-Panabieres C, Pantel K . Clinical relevance and biology of circulating tumor cells. Breast Cancer Res 2011; 13: 228. PubMedPubMed Central Google Scholar
Klein CA . Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009; 9: 302–312. CASPubMed Google Scholar
Janni W, Vogl FD, Wiedswang G, Synnestvedt M, Fehm T, Juckstock J et al. Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse—a European pooled analysis. Clin Cancer Res 2011; 17: 2967–2976. PubMed Google Scholar
Hüsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008; 13: 58–68. PubMed Google Scholar
Podsypanina K, Du YC, Jechlinger M, Beverly LJ, Hambardzumyan D, Varmus H . Seeding and propagation of untransformed mouse mammary cells in the lung. Science 2008; 321: 1841–1844. CASPubMedPubMed Central Google Scholar
Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012; 148: 349–361. CASPubMedPubMed Central Google Scholar
Sänger N, Effenberger KE, Riethdorf S, Van Haasteren V, Gauwerky J, Wiegratz I et al. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ. Int J Cancer 2011; 129: 2522–2526. PubMed Google Scholar
He W, Wang H, Hartmann LC, Cheng JX, Low PS . In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc Natl Acad Sci USA 2007; 104: 11760–11765. CASPubMedPubMed Central Google Scholar
Guzvic M, Braun B, Ganzer R, Burger M, Nerlich M, Winkler S et al. Combined genome and transcriptome analysis of single disseminated cancer cells from bone marrow of prostate cancer patients reveals unexpected transcriptomes. Cancer Res 2014; 74: 7383–7394. CASPubMed Google Scholar
Labelle M, Begum S, Hynes RO . Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011; 20: 576–590. CASPubMedPubMed Central Google Scholar
Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013; 339: 580–584. CASPubMedPubMed Central Google Scholar
LeBleu VS, O'Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC et al. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol 2014; 16: 992–1003 1001-1015. CASPubMedPubMed Central Google Scholar
Tarin D, Thompson EW, Newgreen DF . The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005; 65: 5996–6000; discussion 6000-5991. CASPubMed Google Scholar
Fidler IJ . The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer 1973; 9: 223–227. CASPubMed Google Scholar
Liotta LA, Saidel MG, Kleinerman J . The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 1976; 36: 889–894. CASPubMed Google Scholar
Cho EH, Wendel M, Luttgen M, Yoshioka C, Marrinucci D, Lazar D et al. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys Biol 2012; 9: 016001. PubMedPubMed Central Google Scholar
Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol 2012; 30: 525–532. PubMed Google Scholar
Ni X, Zhuo M, Su Z, Duan J, Gao Y, Wang Z et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci USA 2013; 110: 21083–21088. CASPubMedPubMed Central Google Scholar
Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci USA 2010; 107: 18392–18397. CASPubMedPubMed Central Google Scholar
Labelle M, Hynes RO . The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov 2012; 2: 1091–1099. CASPubMedPubMed Central Google Scholar
Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 2014; 158: 1110–1122. CASPubMedPubMed Central Google Scholar
Bailey CK, Mittal MK, Misra S, Chaudhuri G . High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG. J Biol Chem 2012; 287: 19472–19486. CASPubMedPubMed Central Google Scholar
Holen I, Whitworth J, Nutter F, Evans A, Brown HK, Lefley DV et al. Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo. Breast Cancer Res 2012; 14: R86. CASPubMedPubMed Central Google Scholar
Pantel K, Passlick B, Vogt J, Stosiek P, Angstwurm M, Seen-Hibler R et al. Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer. J Clin Oncol 1998; 16: 1407–1413. CASPubMed Google Scholar
Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004; 10: 6897–6904. PubMed Google Scholar
Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 2013; 31: 539–544. CASPubMed Google Scholar
Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007; 450: 1235–1239. ArticleCASPubMedPubMed Central Google Scholar
Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 2004; 10: 8152–8162. PubMed Google Scholar
Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J et al. Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 2010; 16: 116–122. CASPubMed Google Scholar
Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 2009; 20: 1223–1229. CASPubMed Google Scholar
Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351: 781–791. CASPubMed Google Scholar
de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008; 14: 6302–6309. CASPubMed Google Scholar
Krebs MG, Sloane R, Priest L, Lancashire L, Hou JM, Greystoke A et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 2011; 29: 1556–1563. PubMed Google Scholar
Hodgkinson CL, Morrow CJ, Li Y, Metcalf RL, Rothwell DG, Trapani F et al. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med 2014; 20: 897–903. CASPubMed Google Scholar
Zhang L, Ridgway LD, Wetzel MD, Ngo J, Yin W, Kumar D et al. The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci Transl Med 2013; 5: 180ra148. Google Scholar
Attard G, Swennenhuis JF, Olmos D, Reid AH, Vickers E, A'Hern R et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res 2009; 69: 2912–2918. CASPubMed Google Scholar
Campos M, Prior C, Warleta F, Zudaire I, Ruiz-Mora J, Catena R et al. Phenotypic and genetic characterization of circulating tumor cells by combining immunomagnetic selection and FICTION techniques. J Histochem Cytochem 2008; 56: 667–675. CASPubMedPubMed Central Google Scholar
Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 2008; 359: 366–377. CASPubMedPubMed Central Google Scholar
Heitzer E, Auer M, Gasch C, Pichler M, Ulz P, Hoffmann EM et al. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res 2013; 73: 2965–2975. CASPubMed Google Scholar
Mathiesen RR, Fjelldal R, Liestol K, Due EU, Geigl JB, Riethdorf S et al. High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer. Int J Cancer 2012; 131: E405–E415. CASPubMed Google Scholar
Fiegler H, Geigl JB, Langer S, Rigler D, Porter K, Unger K et al. High resolution array-CGH analysis of single cells. Nucleic Acids Res 2007; 35: e15. PubMed Google Scholar
Hou Y, Song L, Zhu P, Zhang B, Tao Y, Xu X et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 2012; 148: 873–885. CASPubMed Google Scholar
Zong C, Lu S, Chapman AR, Xie XS . Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 2012; 338: 1622–1626. CASPubMedPubMed Central Google Scholar
Van Loo P, Voet T . Single cell analysis of cancer genomes. Curr Opin Genet Dev 2014; 24: 82–91. CASPubMed Google Scholar
Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J et al. Tumour evolution inferred by single-cell sequencing. Nature 2011; 472: 90–94. CASPubMedPubMed Central Google Scholar
Wang Y, Waters J, Leung ML, Unruh A, Roh W, Shi X et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 2014; 512: 155–160. CASPubMedPubMed Central Google Scholar
Heidary M, Auer M, Ulz P, Heitzer E, Petru E, Gasch C et al. The dynamic range of circulating tumor DNA in metastatic breast cancer. Breast Cancer Res 2014; 16: 421. PubMedPubMed Central Google Scholar
Lohr JG, Adalsteinsson VA, Cibulskis K, Choudhury AD, Rosenberg M, Cruz-Gordillo P et al. Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat Biotechnol 2014; 32: 479–484. CASPubMedPubMed Central Google Scholar
Sandberg R . Entering the era of single-cell transcriptomics in biology and medicine. Nat Methods 2014; 11: 22–24. CASPubMed Google Scholar
Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, Deng G et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS ONE 2012; 7: e33788. CASPubMedPubMed Central Google Scholar
Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E et al. Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 1994; 12: 2634–2639. CASPubMed Google Scholar
Xi L, Nicastri DG, El-Hefnawy T, Hughes SJ, Luketich JD, Godfrey TE . Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. Clin Chem 2007; 53: 1206–1215. CASPubMed Google Scholar
Ozkumur E, Shah AM, Ciciliano JC, Emmink BL, Miyamoto DT, Brachtel E et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med 2013; 5: 179ra147. Google Scholar
Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L et al. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med 2010; 2: 25ra23. PubMedPubMed Central Google Scholar
Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med 2014; 371: 1028–1038. PubMedPubMed Central Google Scholar
Yu M, Ting DT, Stott SL, Wittner BS, Ozsolak F, Paul S et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 2012; 487: 510–513. CASPubMedPubMed Central Google Scholar
Ting DT, Wittner BS, Ligorio M, Vincent Jordan N, Shah AM, Miyamoto DT et al. Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells. Cell Rep 2014; 8: 1905–1918. CASPubMedPubMed Central Google Scholar
Pantel K, Deneve E, Nocca D, Coffy A, Vendrell JP, Maudelonde T et al. Circulating epithelial cells in patients with benign colon diseases. Clin Chem 2012; 58: 936–940. CASPubMed Google Scholar
Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010; 464: 999–1005. CASPubMedPubMed Central Google Scholar
Jones S, Chen WD, Parmigiani G, Diehl F, Beerenwinkel N, Antal T et al. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci USA 2008; 105: 4283–4288. CASPubMedPubMed Central Google Scholar
van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530–536. CAS Google Scholar
van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999–2009. CASPubMed Google Scholar
Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883–892. CASPubMedPubMed Central Google Scholar
Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467: 1114–1117. CASPubMedPubMed Central Google Scholar
Campbell PJ, Yachida S, Mudie LJ, Stephens PJ, Pleasance ED, Stebbings LA et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010; 467: 1109–1113. CASPubMedPubMed Central Google Scholar
Nguyen DX, Bos PD, Massague J . Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009; 9: 274–284. CASPubMed Google Scholar
Wan L, Pantel K, Kang Y . Tumor metastasis: moving new biological insights into the clinic. Nat Med 2013; 19: 1450–1464. CASPubMed Google Scholar
Fischer JC, Niederacher D, Topp SA, Honisch E, Schumacher S, Schmitz N et al. Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients. Proc Natl Acad Sci USA 2013; 110: 16580–16585. CASPubMedPubMed Central Google Scholar
Chambers AF, Groom AC, MacDonald IC . Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563–572. CASPubMed Google Scholar
Gao H, Chakraborty G, Lee-Lim AP, Mo Q, Decker M, Vonica A et al. The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell 2012; 150: 764–779. CASPubMedPubMed Central Google Scholar
Lu X, Mu E, Wei Y, Riethdorf S, Yang Q, Yuan M et al. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging alpha4beta1-positive osteoclast progenitors. Cancer Cell 2011; 20: 701–714. CASPubMedPubMed Central Google Scholar
Shiozawa Y, Pedersen EA, Havens AM, Jung Y, Mishra A, Joseph J et al. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest 2011; 121: 1298–1312. CASPubMedPubMed Central Google Scholar
Oskarsson T, Batlle E, Massague J . Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell 2014; 14: 306–321. CASPubMedPubMed Central Google Scholar
Kim MY, Oskarsson T, Acharyya S, Nguyen DX, Zhang XH, Norton L et al. Tumor self-seeding by circulating cancer cells. Cell 2009; 139: 1315–1326. PubMedPubMed Central Google Scholar
Valiente M, Obenauf AC, Jin X, Chen Q, Zhang XH, Lee DJ et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 2014; 156: 1002–1016. CASPubMedPubMed Central Google Scholar
Chen H, Shah AS, Girgis RE, Grossman SA . Transmission of glioblastoma multiforme after bilateral lung transplantation. J Clin Oncol 2008; 26: 3284–3285. PubMed Google Scholar
Müller C, Holtschmidt J, Auer M, Heitzer E, Lamszus K, Schulte A et al. Hematogenous dissemination of glioblastoma multiforme. Sci Transl Med 2014; 6: 247ra101. PubMed Google Scholar
Fonkem E, Lun M, Wong ET . Rare phenomenon of extracranial metastasis of glioblastoma. J Clin Oncol 2011; 29: 4594–4595. PubMed Google Scholar
Seoane J, De Mattos-Arruda L . Escaping out of the brain. Cancer Discov 2014; 4: 1259–1261. CASPubMed Google Scholar
Mandybur TI, Liwnicz BH, Wechsler W . Disseminated (metastatic) tumors in nude mice produced by intravenous injection of cells of human and nonhuman neurogenic tumor lines. Acta Neuropathol 1984; 63: 203–209. CASPubMed Google Scholar
Goss PE, Chambers AF . Does tumour dormancy offer a therapeutic target? Nat Rev Cancer 2010; 10: 871–877. CASPubMed Google Scholar
Kang Y, Pantel K . Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell 2013; 23: 573–581. CASPubMedPubMed Central Google Scholar
Pantel K, Alix-Panabieres C . Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patients. Bonekey Rep 2014; 3: 584. PubMedPubMed Central Google Scholar
Sosa MS, Bragado P, Aguirre-Ghiso JA . Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer 2014; 14: 611–622. CASPubMedPubMed Central Google Scholar
Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 2013; 15: 807–817. CASPubMedPubMed Central Google Scholar
Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC et al. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 2014; 345: 216–220. CASPubMedPubMed Central Google Scholar
Lancaster MA, Knoblich JA . Organogenesis in a dish: modeling development and disease using organoid technologies. Science 2014; 345: 1247125. PubMed Google Scholar
Karthaus WR, Iaquinta PJ, Drost J, Gracanin A, van Boxtel R, Wongvipat J et al. Identification of multipotent luminal progenitor cells in human prostate organoid cultures. Cell 2014; 159: 163–175. CASPubMedPubMed Central Google Scholar
Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A et al. Organoid cultures derived from patients with advanced prostate cancer. Cell 2014; 159: 176–187. CASPubMedPubMed Central Google Scholar
Alix-Panabieres C, Vendrell JP, Pelle O, Rebillard X, Riethdorf S, Muller V et al. Detection and characterization of putative metastatic precursor cells in cancer patients. Clin Chem 2007; 53: 537–539. CASPubMed Google Scholar
Alix-Panabieres C . EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients. Recent Results Cancer Res 2012; 195: 69–76. PubMed Google Scholar
Deneve E, Riethdorf S, Ramos J, Nocca D, Coffy A, Daures JP et al. Capture of viable circulating tumor cells in the liver of colorectal cancer patients. Clin Chem 2013; 59: 1384–1392. CASPubMed Google Scholar
Cayrefourcq L, Mazard T, Joosse S, Solassol J, Ramos J, Assenat E et al. Establishment and characterization of a cell line from human circulating colon cancer cells. Cancer Res 2015; 75: 892–901. CASPubMed Google Scholar
Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012; 481: 506–510. CASPubMedPubMed Central Google Scholar
Almendro V, Cheng YK, Randles A, Itzkovitz S, Marusyk A, Ametller E et al. Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity. Cell Rep 2014; 6: 514–527. CASPubMedPubMed Central Google Scholar
Schwarzenbach H, Hoon DS, Pantel K . Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011; 11: 426–437. CASPubMed Google Scholar
Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 2014; 6: 224ra224. Google Scholar
Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 2013; 368: 1199–1209. CASPubMed Google Scholar
Heitzer E, Auer M, Hoffmann EM, Pichler M, Gasch C, Ulz P et al. Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer. Int J Cancer 2013; 133: 346–356. CASPubMedPubMed Central Google Scholar
Kidess E, Jeffrey SS . Circulating tumor cells versus tumor-derived cell-free DNA: rivals or partners in cancer care in the era of single-cell analysis? Genome Med 2013; 5: 70. PubMedPubMed Central Google Scholar
Pantel K, Alix-Panabieres C . Real-time liquid biopsy in cancer patients: fact or fiction? Cancer Res 2013; 73: 6384–6388. CASPubMed Google Scholar